Upregulation of GP IIb/IIIa receptors during platelet activation: Influence on efficacy of receptor blockade

Thrombosis Research

Volumn 117, Issue 3, 2006, Pages 307-314

  Matzdorff, A ^a   Voss, R ^b  

^a Caritasklinik ^*  (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Flow cytometry; GP IIb IIIa inhibitors; Platelet activation

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; SODIUM CHLORIDE; TIROFIBAN;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE DEPENDENCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; UPREGULATION;

ADENOSINE DIPHOSPHATE; ADULT; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BINDING SITES; BLOOD PLATELETS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, THROMBIN; TIME FACTORS; TYROSINE; UP-REGULATION;

EID: 29244451857     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.03.007     Document Type: Article

References (31)

1. J.H. Chesebro, U. Rauch, V. Fuster, and J.J. Badimon Pathogenesis of thrombosis in coronary artery disease Haemostasis 27 Suppl. 1 1997 12 18
2. D.L. Bhatt, and E.J. Topol Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes JAMA 284 2000 1549 1558
3. N. Chronos, S.J. Marciniak, and M.T. Nakada Binding specificity and associated effects of platelet GP IIb/IIIa inhibitors Eur Heart J Suppl 1 Suppl. E 1999 E11 E17
4. M.A. Mascelli, E.T. Lance, L. Damarju, C.L. Wagner, H.F. Weisman, and R.E. Jordan Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade Circulation 97 1998 1680 1688
5. N.S. Kleiman Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists Coron Artery Dis 9 1998 603 616
6. E.J. Topol, D.J. Moliterno, H.C. Herrmann, E.R. Powers, C.L. Grines, and D.J. Cohen Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary intervention N Engl J Med 344 2001 1888 1894
7. W.E. Boden, and R.G. McKay Optimal treatment of acute coronary syndromes-an evolving strategy N Engl J Med 344 2001 1939 1942
8. R.F. Storey, R.G. Wilcox, and S. Heptinstall Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency Circulation 98 1998 1616 1621
9. N.S. Kleiman, A.E. Raizner, R. Jordan, A.L. Wang, D. Norton, and K.F. Mace Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GP IIb/IIIa receptors J Am Coll Cardiol 26 1995 1665 1671
10. A.C. Matzdorff, G. Kühnel, B. Kemkes-Matthes, and R. Voss Comparison of GP IIb/IIIa inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer J Thromb Thrombolysis 12 2001 129 139
11. P. Harrison, A. Horton, D. Grant, C. Briggs, and S. Machin Immunoplatelet counting: a proposed new reference procedure Br J Haematol 2000 228 235
12. A.C. Matzdorff, G. Kühnel, B. Kemkes-Matthes, and H. Pralle Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry J Lab Clin Med 131 1998 507 517
13. K. Niiya, E. Hodson, R. Bader, V. Byers-Ward, J.A. Koziol, and E.F. Plow Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation Blood 70 1987 475 483
14. G. Escolar, and J.G. White Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies Thromb Haemost 83 2000 371 386
15. G.V.R. Born, and P.D. Richardson Activation time of blood platelets J Membr Biol 57 1980 87 90
16. M. Gawaz, A. Ruf, G. Pogatsa-Murray, T. Dickfeld, S. Rüdiger, and W. Taubitz Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors Thromb Haemost 83 2000 915 922
17. S.A. Mousa, J. Bozarth, M. Forsythe, G. Cain, and A. Slee Platelet GP IIb/IIIa binding characteristics of small molecule RGD mimetics: distinct binding profile for roxifiban and its implications Blood 94 Suppl. 1, Part 1 1999 222a
18. S.J. Marciniak, M.A. Mascelli, M.I. Furman, A.D. Michelson, J.A. Jakubowski, and R.E. Jordan An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates Thromb Haemost 87 2002 1020 1025
19. F.J. Neumann, D. Zohlnhöfer, L. Fakhoury, I. Ott, M. Gawaz, and A. Schömig Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction J Am Coll Cardiol 34 1999 1420 1426
20. M. Gawaz, F.-J. Neumann, I. Ott, A. Schiessler, and A. Schömig Platelet function in acute myocardial infarction treated with direct angioplasty Circulation 93 1996 229 237
21. M. Gawaz, A. Ruf, F.J. Neumann, G. Pogátsa-Murray, T. Dickfeld, and D. Zohlnhöfer Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement Thromb Haemost 80 1998 994 1001
22. S. Lévy-Toledano Platelet signal transduction pathways: could we organize them into a 'hierarchy'? Haemostasis 29 1999 4 15
23. 3) inhibitors Blood 92 1998 3240 3249
24. S. Ndoko, C. Pujol, R. Combrié, A.T. Nurden, and P. Nurden Paradoxical platelet activation was not observed after dissociation of c7E3 (abciximab) from GP IIb/IIIa complexes Thromb Haemost 87 2002 317 322
25. A.L. Frelinger, M.I. Furman, L.A. Krueger, M.R. Barnard, and A.D. Michelson Dissociation of GP IIb-IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation Blood 94 Suppl. 1, Part 1 1999 21a
26. D.J. Schneider, H.C. Herrmann, N. Lakkis, F. Aguirre, Y. Wan, and A. Aggarwal Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban Am J Cardiol 90 2002 1421 1423
27. G.B. Danzi, C. Capuano, M. Sesana, and R. Baglini Preliminary experience with a high bolus dose of tirofiban during percutaneous coronary intervention Curr Med Res Opin 19 2003 28 33
28. A.D. Michelson, P.A. Ellis, M.R. Barnard, G.B. Matic, A.F. Viles, and A.S. Kestin Downregulation fo the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound Blood 77 1991 770 779
29. P. Nurden, C. Bihour, R. Combrié, H. Gralnick, and A.T. Nurden Glycoprotein Ia-IIa (VLA-2) and glycoprotein Ib-IX complexes are processed independently during thrombin-induced platelet activation J Lab Clin Med 124 1994 579 588
30. G. Escolar, K. Clemetson, and J.G. White Persistence of mobile receptors on surface-and suspension-activated platelets J Lab Clin Med 123 1994 536 546
31. J.N. George, L.L. Thoi, and R.K. Morgan Quantitative analysis of platelet membrane glycoproteins: effect of platelet washing procedures and isolation of platelet density subpopulations Thromb Res 23 1981 69 77